Holding Hands: Using Peptide-Drug Conjugates (PDCs) for the Precise Treatment of Pulmonary Fibrosis on November 27, 2024 in East New York, United States

Despite the different strategies, Peptide-Drug Conjugates (PDCs) - that is constructs composed of i) a peptidic/peptidomimetic targeting unit; ii) a linker that connects the targeting unit with the drug; iii) the active payload (drug) - which has emerged as new tools for targeted therapy.